Efficacy of Ganaton (itopride hydrochloride) use in the treatment of patients with functional dyspepsia


Дәйексөз келтіру

Толық мәтін

Аннотация

We assessed the Ganaton (itopride hydrochloride) efficacy in the treatment of 509 patients with functional dyspepsia (FD). We estimated the symptoms severity according to a points system. It noted the frequent combination of PD with heartburn, nausea, bloating, and bowel function disorders. Ganaton administration at a dose of 150 mg daily for 4 weeks contributed to the complete disappearance of complaints in 46.6% of patients and significant decrease in its severity in 47.8% of patients. The drug administration was well tolerated; serious side effects were not observed.

Авторлар туралы

V Ivashkin

A Sheptulin

A Trukhmanov

Әдебиет тізімі

  1. Ивашкин В.Т., Шептулин А.А., Баранская Е.К. и др. Рекомендации по обследованию и лечению больных с синдромом диспепсии. М., 2000. С. 1-7.
  2. Brogden R, Carmine A, Heel R, et al. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as antiemetic. Drugs1982;24:360-400.
  3. Corsetti M, Tack J. Mechnisms of functional dyspepsia and its relation to IBS // Irritable bowel syndrome (Ed. Camilleri M., Spiller M.C.). London 2002:117-26.
  4. Ganaton Post Marketing Surveillance Study Group. Gastroenterology Today 2004;8:1-8.
  5. Holtmann G, Talley NJ, Liebregts T, et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832-40.
  6. Inoue K, Sanada Y, Fijimura J, et al. Clinical effect of itopride hydrochloride on the digestive symptoms of chronic gastritis with reflux esophagitis. Clinical Medicine 1999;15:1803-08.
  7. Karamanolis G, Tack J. Promotility medications - now and in the future. Dig Dis 2006;24:297-307.
  8. Moayyedi P, Soo S, Deeks J, et al. Systemic review: Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003;17:1215-27.
  9. Sawant P, Das HS, Desai N, et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. JAPI 2004;52:626-28.
  10. Smout AJPM, Akkermans LMA. Normal and disturbed motility of the gastrointestinal tract. Wrightson Biomedical Publishing Ltd. - Petersfield.
  11. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
  12. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2373&mid=1085056570&magid=177

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2009